Identification of Human Pancreatic Cancer Stem Cells

  • Chenwei Li
  • C. J. Lee
  • Diane M. Simeone
Part of the Methods in Molecular Biology book series (MIMB, volume 568)


Emerging evidence suggests that malignant tumors are composed of a small subset of distinct cancer cells, termed “cancer stem cells” (typically less than 5% of total cancer cells based on cell surface marker expression), which have great proliferative potential, as well as more differentiated cancer cells, which have very limited proliferative potential. Data have been provided to support the existence of cancer stem cells in several different types of cancer, including human blood, brain, prostate, ovarian, melanoma, colon, and breast cancers. We have recently reported the identification of a subpopulation of pancreatic cancer cells that express the cell surface markers CD44+CD24+ESA+ (0.2–0.8% of all human pancreatic cancer cells) that function as pancreatic cancer stem cells. The CD44+CD24+ESA+ pancreatic cancer cells are highly tumorigenic and possess the stem cell-like properties of self-renewal and the ability to produce differentiated progeny. Pancreatic cancer stem cells also demonstrate upregulation of molecules important in developmental signaling pathways, including sonic hedgehog and the polycomb gene family member Bmi-1. Of clinical importance, cancer stem cells in several tumor types have shown resistance to standard therapies and may play a role in treatment failure or disease recurrence. Identification of pancreatic cancer stem cells and further elucidation of the signaling pathways that regulate their growth and survival may provide novel therapeutic approaches to treat pancreatic cancer, which is notoriously resistant to standard chemotherapy and radiation.

Key words

Pancreatic cancer stem cells niche CD44 ESA CD24 NOD/SCID xenografts tumorigenic potential self-renewal 


  1. 1.
    Hoyert DL, Heron MP, Murphy SL, Kung HC. (2006) Deaths: final data for 2003. Natl Vital Stat Rep 19: 1–120.Google Scholar
  2. 2.
    Bonnet D, Dick JE. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med 3: 730–737.PubMedCrossRefGoogle Scholar
  3. 3.
    Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. (1994) A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 17: 645–648.CrossRefGoogle Scholar
  4. 4.
    Matsui W, Huff CA, Wang Q, et al. (2004) Characterization of clonagenic multiple myeloma cells. Blood 103: 2332–2336.PubMedCrossRefGoogle Scholar
  5. 5.
    Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983–3988.PubMedCrossRefGoogle Scholar
  6. 6.
    Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. (2004) Identification of human brain tumour initiating cells. Nature 432: 396–401.PubMedCrossRefGoogle Scholar
  7. 7.
    Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65(23): 10946–10951.PubMedCrossRefGoogle Scholar
  8. 8.
    O’Brien CA, Pollett A, Gallinger S, Dick JE. (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123): 106–110.PubMedCrossRefGoogle Scholar
  9. 9.
    Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445(7123):111–115.PubMedCrossRefGoogle Scholar
  10. 10.
    Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM. (2007) Identification of pancreatic cancer stem cells. Cancer Res 67(3): 1030–1037.PubMedCrossRefGoogle Scholar
  11. 11.
    Li L, Neaves WB. (2006) Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66: 4553–4557.PubMedCrossRefGoogle Scholar
  12. 12.
    Hahn SA, Seymour AB, Hoque AT, et. al. (1995) Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 55: 4670–4675.PubMedGoogle Scholar
  13. 13.
    Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM. (2006) Cancer stem cells – Perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 66(19): 9339–9344.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Chenwei Li
    • 1
  • C. J. Lee
    • 1
  • Diane M. Simeone
    • 1
  1. 1.Department of SurgeryUniversity of MichiganAnn ArborUSA

Personalised recommendations